Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Reischl

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 21, 2019
Special Issue "Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine"Gerald Reischl
Neuroimage|December 10, 2013
Assessment of rodent brain activity using combined [(15)O]H2O-PET and BOLD-fMRIHans F Wehrl, Petros Martirosian, Fritz Schick, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 16, 2019
Fast enzymatic synthesis of n.c.a. 6-[<sup>18</sup> F]fluorodopamine (FDA) from n.c.a. 6-[<sup>18</sup> F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptakeZyrafete Kuçi, Walter Ehrlichmann, Jörg Sauer, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 30, 2008
Radioiodination of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studiesAnke Stahlschmidt, Hans-Jürgen Machulla, Gerald Reischl, et al.
Journal of Neurochemistry|August 18, 2004
DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracerRené Hummerich, Gerald Reischl, Walter Ehrlichmann, et al.
Pharmaceuticals (Basel, Switzerland)|May 17, 2014
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled RadiopharmaceuticalsMatthias Kuntzsch, Denis Lamparter, Nils Brüggener, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 28, 2018
Smoking moderates association of 5-HTTLPR and in vivo availability of serotonin transportersMichael N Smolka, Matthias Reimold, Andrea Kobiella, et al.
Neuroimage|September 28, 2011
In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PETKristina Fischer, Vesna Sossi, Andreas von Ameln-Mayerhofer, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 8, 2007
Decarbonylation of multi-substituted [18F]benzaldehydes for modelling syntheses of 18F-labelled aromatic amino acidsBin Shen, Dirk Löffler, Klaus-Peter Zeller, et al.
Human Brain Mapping|June 15, 2006
Dose-dependent attenuation of auditory phantom perception (tinnitus) by PET-guided repetitive transcranial magnetic stimulationChristian Plewnia, Matthias Reimold, Arif Najib, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Pharmaceuticals (Basel, Switzerland)|July 21, 2019
Special Issue "Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine"Gerald Reischl
Neuroimage|December 10, 2013
Assessment of rodent brain activity using combined [(15)O]H2O-PET and BOLD-fMRIHans F Wehrl, Petros Martirosian, Fritz Schick, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 16, 2019
Fast enzymatic synthesis of n.c.a. 6-[<sup>18</sup> F]fluorodopamine (FDA) from n.c.a. 6-[<sup>18</sup> F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptakeZyrafete Kuçi, Walter Ehrlichmann, Jörg Sauer, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 30, 2008
Radioiodination of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studiesAnke Stahlschmidt, Hans-Jürgen Machulla, Gerald Reischl, et al.
Journal of Neurochemistry|August 18, 2004
DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracerRené Hummerich, Gerald Reischl, Walter Ehrlichmann, et al.
Pharmaceuticals (Basel, Switzerland)|May 17, 2014
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled RadiopharmaceuticalsMatthias Kuntzsch, Denis Lamparter, Nils Brüggener, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 28, 2018
Smoking moderates association of 5-HTTLPR and in vivo availability of serotonin transportersMichael N Smolka, Matthias Reimold, Andrea Kobiella, et al.
Neuroimage|September 28, 2011
In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PETKristina Fischer, Vesna Sossi, Andreas von Ameln-Mayerhofer, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 8, 2007
Decarbonylation of multi-substituted [18F]benzaldehydes for modelling syntheses of 18F-labelled aromatic amino acidsBin Shen, Dirk Löffler, Klaus-Peter Zeller, et al.
Human Brain Mapping|June 15, 2006
Dose-dependent attenuation of auditory phantom perception (tinnitus) by PET-guided repetitive transcranial magnetic stimulationChristian Plewnia, Matthias Reimold, Arif Najib, et al.
Pageof 11